Phase 2/3 trial of new omicron-targeted vaccine shows efficacy in adolescents
A single dose of the mRNA-1273.222 vaccine demonstrated strong immune responses against various omicron subvariants and showed a favorable safety profile compared to existing vaccines.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
Pertussis rates continue to rise in the United States
A look into CDC numbers for increasing pertussis cases in the United States, along with commentary from our editor-in-chief, Tina Tan, MD, FAAP, FIDSA, FPIDS.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
Tina Tan, MD, FAAP, FIDSA, FPIDS, previews big topics at the 2024 AAP National Conference & Exhibition
Our editor-in-chief Tina Tan, MD, FAAP, FIDSA, FPIDS, previews some of the American Academy of Pediatrics National Conference & Exhibition, taking place right now in Orlando, Florida.
FDA approves FluMist for self- or caregiver-administration
With this approval, FluMist becomes the first vaccine to prevent influenza that does not need to be administered by a health care provider.
